Literature DB >> 22197533

Risk factor analysis for second-stage palliation of single ventricle anatomy.

Timothy M Lee1, Ranjit Aiyagari, Jennifer C Hirsch, Richard G Ohye, Edward L Bove, Eric J Devaney.   

Abstract

BACKGROUND: Single ventricle hearts can be surgically palliated by a series of operations culminating in the Fontan procedure, which establishes a total cavopulmonary connection. The second-stage procedure creates a physiologic connection between the superior vena cava and the pulmonary artery.
METHODS: From 1998 to 2010, 557 patients with single ventricle heart disease underwent second-stage surgical palliation. This cohort was retrospectively analyzed to assess patient outcome by a number of anatomic, physiologic, and procedural factors. The analysis excluded patients undergoing hybrid first-stage procedures.
RESULTS: The median age at operation was 165 days (range, 59 days to 49 years). The most common anatomic subtypes were hypoplastic left heart syndrome (52%), tricuspid atresia (12%), unbalanced atrioventricular septal defect (10%), double inlet left ventricle (9%), or other (17%). Left ventricular hypoplasia was present in 70%. A hemi-Fontan procedure was done in 89%, and 11% received a bidirectional Glenn. Concomitant atrioventricular valve repair was necessary in 9%. Early mortality was 4.7%, and 5.9% died after discharge but before Fontan. No early or late deaths occurred in patients with tricuspid atresia and double inlet left ventricle. Multivariate analysis demonstrated ventricular dysfunction, atrioventricular valve regurgitation, and unbalanced atrioventricular septal defect were significant adverse risk factors for survival to Fontan.
CONCLUSIONS: Second-stage palliation can be performed at low risk for patients with left ventricular dominance, but significant risk remains for patients with left ventricular hypoplasia and unbalanced atrioventricular septal defect. Atrioventricular valve insufficiency is a persistent problem that has not been neutralized by repair strategies.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22197533     DOI: 10.1016/j.athoracsur.2011.10.012

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  16 in total

1.  First-in-Human Closed-Chest Transcatheter Superior Cavopulmonary Anastomosis.

Authors:  Kanishka Ratnayaka; John W Moore; Rodrigo Rios; Robert J Lederman; Sanjeet R Hegde; Howaida G El-Said
Journal:  J Am Coll Cardiol       Date:  2017-08-08       Impact factor: 24.094

2.  Stem cells on a new stage: Treatment of hypoplastic left heart syndrome.

Authors:  Sunjay Kaushal; Brody Wehman
Journal:  J Thorac Cardiovasc Surg       Date:  2015-07-10       Impact factor: 5.209

3.  Predictors of Prolonged Hospital Length of Stay Following Stage II Palliation of Hypoplastic Left Heart Syndrome (and Variants): Analysis of the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) Database.

Authors:  Carissa M Baker-Smith; Sara W Goldberg; Geoffrey L Rosenthal
Journal:  Pediatr Cardiol       Date:  2015-06-03       Impact factor: 1.655

4.  Elevated Pulmonary Artery Pressure, Not Pulmonary Vascular Resistance, is an Independent Predictor of Short-Term Morbidity Following Bidirectional Cavopulmonary Connection.

Authors:  Susanna Tran; Patrick M Sullivan; John Cleveland; S Ram Kumar; Cheryl Takao
Journal:  Pediatr Cardiol       Date:  2018-06-14       Impact factor: 1.655

5.  Characteristics of Hospitalizations for the Glenn Procedure in Those With Isomerism Compared to Those Without.

Authors:  Rohit S Loomba; Peter C Kouretas; Robert H Anderson
Journal:  Pediatr Cardiol       Date:  2016-07-08       Impact factor: 1.655

6.  Relationship of Ventricular Morphology and Atrioventricular Valve Function to Long-Term Outcomes Following Fontan Procedures.

Authors:  Jiyong Moon; Li Shen; Donald S Likosky; Vikram Sood; Reilly D Hobbs; Peter Sassalos; Jennifer C Romano; Richard G Ohye; Edward L Bove; Ming-Sing Si
Journal:  J Am Coll Cardiol       Date:  2020-07-28       Impact factor: 24.094

Review 7.  Stem cell therapy for CHD: towards translation.

Authors:  Brody Wehman; Osama T Siddiqui; Rachana Mishra; Sudhish Sharma; Sunjay Kaushal
Journal:  Cardiol Young       Date:  2015-08       Impact factor: 1.093

8.  The Optimal Timing of Stage 2 Palliation for Hypoplastic Left Heart Syndrome: An Analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Data Set.

Authors:  James M Meza; Edward J Hickey; Eugene H Blackstone; Robert D B Jaquiss; Brett R Anderson; William G Williams; Sally Cai; Glen S Van Arsdell; Tara Karamlou; Brian W McCrindle
Journal:  Circulation       Date:  2017-07-07       Impact factor: 29.690

9.  A Growth-Accommodating Implant for Paediatric Applications.

Authors:  Eric N Feins; Yuhan Lee; Eoin D O'Cearbhaill; Nikolay V Vasilyev; Shogo Shimada; Ingeborg Friehs; Douglas Perrin; Peter E Hammer; Haruo Yamauchi; Gerald Marx; Andrew Gosline; Veaceslav Arabagi; Jeffrey M Karp; Pedro J Del Nido
Journal:  Nat Biomed Eng       Date:  2017-10-10       Impact factor: 25.671

10.  Proteomic profiling identifies key differences between inter-stage infants with single ventricle heart disease and healthy controls.

Authors:  Benjamin S Frank; Ludmila Khailova; Lori Silveira; Max B Mitchell; Gareth J Morgan; Elena W Y Hsieh; Michael V DiMaria; Mark Twite; Jelena Klawitter; Jesse A Davidson
Journal:  Transl Res       Date:  2020-10-09       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.